Skip to content

Marc Berger, M.D.

NPI 1598972325ActiveIndividual· Internal Medicine· New York, NY

Internal Medicine (M.D.) in New York, New York, licensed in NY, with an NPI issued in May 2007. Part D covered 48 prescriptions written in 2024, 92% of them generic. Regeneron Pharmaceuticals, Inc. was the largest of 2 companies reporting payments in 2025, $8,374 in all, mostly consulting fees.

Overview

NPI1598972325
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedMay 17, 2007
Last updated in NPPESMay 13, 2024
Certified by providerMay 13, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X141461-1NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)48 · 52 30-day fills
Total drug cost$283.46
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$8,374 · 5 payments from 2 companies
  • 2024$34,017 · 9 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Regeneron Pharmaceuticals, Inc.$5,1482
Mylan Inc.$3,2263

What the 2025 payments were for

  • Consulting Fee$8,374 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in New York

All Internal Medicine providers in New York →